|
VOLUME 29: NO.6 JUNE 2002
Editorials
Who Should Look After Patients with Mild Lupus?
 R.H. Glazier .........1115
Is It Time for Rheumatologists to Rethink the
Use of Manual Therapies?
 M-A. Fitzcharles .........1117
Ankylosing Spondylitis: What Do We Really Know About the Onset and Progression of This Disease?
 M.C.W. Creemers .........1121
Articles
Aberrant Responsiveness to RANTES in SF
T Cells from Patients with RA
 N. Hisakawa, H. Tanaka, O. Hosono, et al .........1124
Immunoglobulin G Fc-Receptor (FcgR) IIA, IIIA, and IIIB Polymorphisms Related to Disease Severity in RA
 J.G. Brun, T.M. Madland, C.A. Vedeler .........1135
The Ogryzlo Day Lecture: Premature Immunosenescence in RA
 C.M. Weyand, J.J. Goronzy .........1141
The Effect of Health Related Quality of Life on Reported Use of Health Care Resources in Patients with OA and RA: a Longitudinal Analysis
 O. Ethgen, K.H. Kahler, S.X. Kong, J-Y. Reginster,
F. Wolfe .........1147
A Cost Effectiveness Analysis of Treatment
Options for MTX-Naive RA
 H.K. Choi, J.D. Seeger, K.M. Kuntz .........1156
Prevalence of RA in Tucumán, Argentina
 A. Spindler, V. Bellomio, A. Berman, et al .........1166
Treatment of Chronic Knee Synovitis with Arthroscopic Synovectomy: Longterm Results
 F. Roch-Bras, J-P. Daurès, M-C. Legouffe,
J. Sany, B. Combe .........1171
Antigen Induced Arthritis (AIA) Can Be Transferred by Bone Marrow Transplantation: Evidence That
IL-6 Is Essential for Induction of AIA
 H. Kobayashi, S. Ohshima, K. Nishioka, et al .........1176
A Functional Polymorphism in Fas (CD95/APO-1) Gene Promoter Associated with SLE
 S. Kanemitsu, K. Ihara, A. Saifddin, et al .........1183
Transforming Growth Factor-ß2 Polymorphism and Systemic Lupus Erythematosus
 A. Alansari, A. Hajeer, L-S. Teh, et al .........1189
Gene Polymorphisms of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Patients with Antiphospholipid Antibodies
 S. Yasuda, A. Tsutsumi, T. Atsumi, et al .........1192
Hospital Experience and Mortality in Patients
with SLE: Which Patients Benefit Most from Treatment at Highly Experienced Hospitals?
 M.M. Ward .........1198
Role of Specialty Care in the Management of Patients with SLE
 M.B. Urowitz, A. Kagal,
P. Rahman, D.D. Gladman .........1207
No Association of Vitamin D Receptor Gene Start Codon Fok I Polymorphisms in Chinese Patients with SLE
 C-M. Huang, M-C. Wu, J-Y. Wu, F-J. Tsai .........1211
Risk Factors of Mortality for Salmonella
Infection in SLE
 C-H. Tsao, C-Y. Chen, L-S. Ou, J-L. Huang .........1214
Sex Differences in Giant Cell Arteritis
 R. Nir-Paz, A. Gross, T. Chajek-Shaul .........1219
The Predictive Value of the Halo Sign in Color Doppler Ultrasonography of the Temporal Arteries for Diagnosing GCA
 G. Nesher, D. Shemesh, M. Mates, M. Sonnenblick,
H.B. Abramowitz .........1224
Parvoviral Infection of Endothelial Cells and Its Possible Role in Vasculitis and Autoimmune Diseases
 C.M. Magro, A.N. Crowson,
M. Dawood, G.J. Nuovo .........1227
The Natural History of Ankylosing Spondylitis as Defined by Radiological Progression
 S. Brophy, K. MacKay, A. Al-Saidi, G. Taylor,
A. Calin .........1236
Accelerated Alveolar Bone Loss in HLA-B27 Transgenic Rats: An Adult Onset Condition
 D.N. Tatakis, P. Guglielmoni, H.M. Fletcher .........1244
Corticotropin Releasing Hormone (CRH) Antagonist Attenuates Adjuvant Induced Arthritis: Role of CRH in Peripheral Inflammation
 E.L. Webster,
R.M. Barrientos, C. Contoreggi, et al .........1252
Interleukin 17 (IL-17) Induces Collagenase-3 Production in Human Osteoarthritic Chondrocytes via AP-1 Dependent Activation: Differential Activation of AP-1 Members by IL-17 and IL-1ß
 M. Benderdour, G. Tardif, J-P. Pelletier, et al .........1262
The Importance of Patient Expectations in Predicting Functional Outcomes After
Total Joint Arthroplasty
 N.N. Mahomed, M.H. Liang, E.F. Cook, et al .........1273
Improving Physical Functional Status in
Patients with FM: A Brief Cognitive Behavioral Intervention
 D.A. Williams, M.A. Cary, K.H. Groner, et al .........1280
Effects of Strength Training on Muscle Strength, Cross-Sectional Area, Maximal Electromyographic Activity, and Serum Hormones in Premenopausal Women with FM
 K. Häkkinen, A. Pakarinen, P. Hannonen, et al .........1287
Pediatric Rheumatology
Linear Growth and Final Height in Patients with Systemic JIA Treated with Longterm
Glucocorticoids
 D. Simon, C. Fernando, P. Czernichow,
A-M. Prieur .........1296
Immunohistologic Analysis of CD59 and Membrane Attack Complex of Complement in Muscle in JDM
 F.G.P. Gonçalves, L. Chimelli, A.M.E. Sallum,
S.K.N. Marie, M.H.B. Kiss, V.P.L. Ferriani .........1301
Workshop Report: Which Is the Best Radiographic Protocol for a Clinical Trial of a Structure Modifying Drug in Patients with Knee Osteoarthritis?
 K.D. Brandt, S.A. Mazzucca, T. Conrozier, et al .........1308
Rheumatologica Historica: The Treatment of Acute Rheumatism by Salicin, by T.J. Maclagan -- The Lancet, 1876
 W.W. Buchanan, W.F. Kean .........1321
Case Reports
Familial Mediterranean Fever in 2 Japanese
Families
 K. Shinozaki, K. Agematsu, K. Yasui, et al .........1324
Cutaneous T Cell Lymphoma in a Patient with Primary Biliary Cirrhosis and Secondary SS
 A. Stroehmann, T. Dörner, A. Lukowsky, E. Feist,
F. Hiepe, G-R. Burmester .........1326
Concurrent Occurrence of Chylothorax, Chylous Ascites, and Protein-Losing Enteropathy in SLE
 C-K. Lee, J.M. Han, K.N. Lee, et al .........1330
New Onset SLE with Pheochromocytoma
 A.T.H. Lin, Y. Min, P.J. Clements, et al .........1334
Images in Rheumatology
Diagnostic Usefulness of 3 Dimensional Gadolinium Enhanced Magnetic Resonance Venography in APS
 H. Erel, D. Erkan, T.J. Lehman, M.R. Prince .........1338
Trochanteric Bursitis in RA
 H. Tanaka, K. Kido, A. Wakisaka, T. Mine,
S. Kawai .........1340
Correspondence
Total Hip Arthroplasty in Ankylosing Spondylitis
M.A. Khan .........1342
Reply A. Calin .........1342
Letters
Failure to Detect Antibodies to Extracellular Loop Peptides of the Muscarinic M3 Receptor in Primary SS D. Cavill, S.A. Waterman, T.P. Gordon .........1342
Notices .........ix
|